{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:37:57Z","timestamp":1792784277074,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015539","name":"Commonwealth of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015539","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2034108"],"award-info":[{"award-number":["2034108"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/011kf5r70","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2034282"],"award-info":[{"award-number":["2034282"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/011kf5r70","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2033318"],"award-info":[{"award-number":["2033318"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/011kf5r70","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2026360"],"award-info":[{"award-number":["2026360"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/011kf5r70","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100025520","name":"Medical Research Future Fund","doi-asserted-by":"publisher","award":["2015313"],"award-info":[{"award-number":["2015313"]}],"id":[{"id":"10.13039\/501100025520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025520","name":"Medical Research Future Fund","doi-asserted-by":"publisher","award":["2016062"],"award-info":[{"award-number":["2016062"]}],"id":[{"id":"10.13039\/501100025520","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Microbe"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.lanmic.2026.101424","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:09:03Z","timestamp":1789502943000},"page":"101424","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["COVID-19 vaccine effectiveness in people on immunosuppressive therapies: a systematic review and meta-analysis"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5129-8180","authenticated-orcid":false,"given":"Eva","family":"Stadler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0772-6122","authenticated-orcid":false,"given":"Shanchita R","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4989-5552","authenticated-orcid":false,"given":"Karen M","family":"Elias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ece","family":"Egilmezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chansavath","family":"Phetsouphanh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Hastak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehana V","family":"Hewavisenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchika V","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tari","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Cromer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah C","family":"Sasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles P","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2663-1551","authenticated-orcid":false,"given":"David S","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanmic.2026.101424_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0257641","article-title":"COVID-19-related outcomes in immunocompromised patients: A nationwide study in Korea","volume":"16","author":"Baek","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.lanmic.2026.101424_bib2","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/j.jinf.2020.05.017","article-title":"Impacts of immunosuppression and immunodeficiency on COVID-19: a systematic review and meta-analysis","volume":"81","author":"Gao","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.lanmic.2026.101424_bib3","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/S2665-9913(21)00325-8","article-title":"Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the National COVID Cohort Collaborative","volume":"4","author":"Andersen","year":"2022","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.lanmic.2026.101424_bib4","article-title":"Factors associated with deaths due to COVID-19 versus other causes: population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform","volume":"6","author":"Bhaskaran","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.lanmic.2026.101424_bib5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12929-022-00853-8","article-title":"COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection","volume":"29","author":"Chi","year":"2022","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.lanmic.2026.101424_bib6","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0140-6736(24)02560-1","article-title":"Impact of SARS-CoV-2 spike antibody positivity on infection and hospitalisation rates in immunosuppressed populations during the omicron period: the MELODY study","volume":"405","author":"Mumford","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.lanmic.2026.101424_bib7","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1136\/annrheumdis-2021-220597","article-title":"Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease","volume":"80","author":"Haberman","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lanmic.2026.101424_bib8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/ajh.26619","article-title":"Patients with treated indolent lymphomas immunized with BNT162b2 have reduced anti-spike neutralizing IgG to SARS-CoV-2 variants, but preserved antigen-specific T cell responses","volume":"98","author":"Beaton","year":"2023","journal-title":"Am J Hematol"},{"key":"10.1016\/j.lanmic.2026.101424_bib9","article-title":"Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies","volume":"14","author":"Achiron","year":"2021","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.lanmic.2026.101424_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-068632","article-title":"Efficacy of COVID-19 vaccines in immunocompromised patients: systematic review and meta-analysis","volume":"376","author":"Lee","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.lanmic.2026.101424_bib11","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.cgh.2022.02.030","article-title":"Effectiveness and durability of COVID-19 vaccination in 9447 patients with IBD: a systematic review and meta-analysis","volume":"20","author":"Jena","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.lanmic.2026.101424_bib12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.31662\/jmaj.2023-0171","article-title":"Efficacy of COVID-19 vaccines in patients with hematological malignancy compared to healthy controls: a systematic review and meta-analysis","volume":"7","author":"Barshan","year":"2024","journal-title":"JMA J"},{"key":"10.1016\/j.lanmic.2026.101424_bib13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jinf.2021.12.035","article-title":"Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: a systematic literature review and meta-analysis","volume":"84","author":"Marra","year":"2022","journal-title":"J Infect"},{"key":"10.1016\/j.lanmic.2026.101424_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.1259","article-title":"Immunocompromised individuals are at increased risk of COVID-19 breakthrough infection, hospitalization, and death in the post-vaccination era: a systematic review","volume":"12","author":"Bytyci","year":"2024","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.lanmic.2026.101424_bib15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cmi.2021.09.036","article-title":"Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review","volume":"28","author":"Galmiche","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.lanmic.2026.101424_bib16","doi-asserted-by":"crossref","DOI":"10.1017\/ash.2024.369","article-title":"Effectiveness of heterologous and homologous COVID-19 vaccination among immunocompromised individuals: a systematic literature review and meta-analysis","volume":"4","author":"Pardo","year":"2024","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"10.1016\/j.lanmic.2026.101424_bib17","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v104.40009","article-title":"Immunogenicity, effectiveness, and safety of COVID-19 vaccines among patients with immune-mediated dermatological diseases: a systematic review and meta-analysis","volume":"104","author":"Chirasuthat","year":"2024","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.lanmic.2026.101424_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1016927","article-title":"Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases","volume":"13","author":"Raptis","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.lanmic.2026.101424_bib19","author":"Wells"},{"key":"10.1016\/j.lanmic.2026.101424_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"key":"10.1016\/j.lanmic.2026.101424_bib21","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1016\/S2666-5247(21)00267-6","article-title":"Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis","volume":"3","author":"Cromer","year":"2022","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.lanmic.2026.101424_bib22","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.lanmic.2026.101424_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104548","article-title":"Effectiveness of BBIBP-CorV vaccine in preventing SARS-CoV-2 infection and severe outcomes in people living with multiple sclerosis: a population-based study","volume":"71","author":"Barzegar","year":"2023","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.lanmic.2026.101424_bib24","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.15585\/mmwr.mm7142a4","article-title":"Effectiveness of COVID-19 mRNA vaccines against COVID-19-associated hospitalizations among immunocompromised adults during SARS-CoV-2 omicron predominance\u2014VISION network, 10 states, December 2021\u2013August 2022","volume":"71","author":"Britton","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.lanmic.2026.101424_bib25","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1002\/art.42287","article-title":"Breakthrough SARS-CoV-2 infections in patients with immune-mediated disease undergoing B cell\u2013depleting therapy: a retrospective cohort analysis","volume":"74","author":"Calabrese","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.lanmic.2026.101424_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.113603","article-title":"Effectiveness and safety of COVID-19 vaccination in people with blood cancer","volume":"201","author":"Copland","year":"2024","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.lanmic.2026.101424_bib27","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/ibd\/izac252","article-title":"Effect of 2 vs 3 doses of COVID-19 vaccine in patients with inflammatory bowel disease: a population-based propensity matched analysis","volume":"29","author":"Desai","year":"2023","journal-title":"Inflam Bowel Dis"},{"key":"10.1016\/j.lanmic.2026.101424_bib28","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/ajt.16641","article-title":"Effectiveness of 2-dose vaccination with mRNA COVID-19 vaccines against COVID-19\u2013associated hospitalizations among immunocompromised adults\u2014nine States, January\u2013September 2021","volume":"22","author":"Embi","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.lanmic.2026.101424_bib29","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1016\/j.vaccine.2023.05.038","article-title":"Effectiveness of COVID-19 vaccines at preventing emergency department or urgent care encounters and hospitalizations among immunocompromised adults: an observational study of real-world data across 10 US states from August\u2013December 2021","volume":"41","author":"Embi","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.lanmic.2026.101424_bib30","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3390\/vaccines12050453","article-title":"COVID-19 vaccine effectiveness among patients with psoriatic disease: A population-based study","volume":"12","author":"Gazitt","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.lanmic.2026.101424_bib31","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1053\/j.gastro.2021.05.044","article-title":"Effectiveness of SARS-CoV-2 vaccination in a Veterans Affairs cohort of patients with inflammatory bowel disease with diverse exposure to immunosuppressive medications","volume":"161","author":"Khan","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lanmic.2026.101424_bib32","doi-asserted-by":"crossref","first-page":"664","DOI":"10.14309\/ajg.0000000000002071","article-title":"COVID-19 vaccine effectiveness against the omicron variant in a Veterans Affairs cohort of patients with inflammatory bowel disease","volume":"118","author":"Khan","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.lanmic.2026.101424_bib33","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1038\/s41467-024-49285-y","article-title":"Effectiveness of COVID-19 vaccines against severe COVID-19 among patients with cancer in Catalonia, Spain","volume":"15","author":"Lazar Neto","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.lanmic.2026.101424_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2022.06.038","article-title":"COVID-19: third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: a population-based study","volume":"175","author":"Lee","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.lanmic.2026.101424_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104033","article-title":"COVID-19 infection and vaccination against COVID-19: impact on managing demyelinating CNS disorders in Southern India-experience from a demyelinating disease registry","volume":"66","author":"Pandit","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.lanmic.2026.101424_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0283538","article-title":"Multiple sclerosis and COVID-19: a retrospective study in Iran","volume":"18","author":"Sedighi","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.lanmic.2026.101424_bib37","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.48664","article-title":"Analysis of rituximab use, time between rituximab and SARS-CoV-2 vaccination, and COVID-19 hospitalization or death in patients with multiple sclerosis","volume":"5","author":"Smith","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.lanmic.2026.101424_bib38","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1007\/s00415-023-11935-4","article-title":"Risk of breakthrough COVID-19 after vaccination among people with multiple sclerosis on disease-modifying therapies","volume":"270","author":"Spierer","year":"2023","journal-title":"J Neurol"},{"key":"10.1016\/j.lanmic.2026.101424_bib39","doi-asserted-by":"crossref","first-page":"e430","DOI":"10.1016\/S2665-9913(22)00096-0","article-title":"Vaccine effectiveness against SARS-CoV-2 infection and severe outcomes among individuals with immune-mediated inflammatory diseases tested between March 1 and Nov 22, 2021, in Ontario, Canada: a population-based analysis","volume":"4","author":"Widdifield","year":"2022","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.lanmic.2026.101424_bib40","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/jamaoncol.2021.5771","article-title":"Association of COVID-19 vaccination with SARS-CoV-2 infection in patients with cancer: a US nationwide Veterans Affairs study","volume":"8","author":"Wu","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.lanmic.2026.101424_bib41","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003400","article-title":"COVID-19 Vaccine in Immunosuppressed Adults with Autoimmune rheumatic Diseases (COVIAAD): safety, immunogenicity and antibody persistence at 12 months following Moderna Spikevax primary series","volume":"9","author":"Colmegna","year":"2023","journal-title":"RMD Open"},{"key":"10.1016\/j.lanmic.2026.101424_bib42","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1080\/13696998.2021.2002063","article-title":"Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2","volume":"24","author":"Di Fusco","year":"2021","journal-title":"J Med Econ"},{"key":"10.1016\/j.lanmic.2026.101424_bib43","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3899\/jrheum.2023-0357","article-title":"Effect of secukinumab and tumor necrosis factor inhibitors on humoral response to BNT162b2 mRNA vaccine in patients with spondyloarthritis compared to immunocompetent controls","volume":"51","author":"Eviatar","year":"2024","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lanmic.2026.101424_bib44","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1001\/jamaoncol.2022.6815","article-title":"Association of COVID-19 vaccination with breakthrough infections and complications in patients with cancer","volume":"9","author":"Gong","year":"2023","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.lanmic.2026.101424_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1221587","article-title":"Dynamics of humoral and cellular response to three doses of anti-SARS-CoV-2 BNT162b2 vaccine in patients with hematological malignancies and older subjects","volume":"14","author":"Laquintana","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.lanmic.2026.101424_bib46","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1053\/j.seminoncol.2022.07.005","article-title":"Influence of cancer on COVID-19 incidence, outcomes, and vaccine effectiveness: a prospective cohort study of U.S. Veterans","volume":"49","author":"Leuva","year":"2022","journal-title":"Semin Oncol"},{"key":"10.1016\/j.lanmic.2026.101424_bib47","doi-asserted-by":"crossref","first-page":"e1263","DOI":"10.1016\/j.cgh.2021.12.026","article-title":"COVID-19 vaccine is effective in inflammatory bowel disease patients and is not associated with disease exacerbation","volume":"20","author":"Lev-Tzion","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.lanmic.2026.101424_bib48","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/acr.25028","article-title":"Risk of COVID-19 among unvaccinated and vaccinated patients with rheumatoid arthritis: a general population study","volume":"75","author":"Li","year":"2023","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.lanmic.2026.101424_bib49","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1177\/09612033241273052","article-title":"Anti-SARS-CoV-2 mRNA vaccination among patients living with SLE in Sweden: coverage and clinical effectiveness","volume":"33","author":"Mageau","year":"2024","journal-title":"Lupus"},{"key":"10.1016\/j.lanmic.2026.101424_bib50","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1038\/s41591-021-01469-5","article-title":"Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial","volume":"27","author":"Medeiros-Ribeiro","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.lanmic.2026.101424_bib51","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1182\/blood.2021013768","article-title":"Effectiveness of the BNT162b2mRNA COVID-19 vaccine in patients with hematological neoplasms in a nationwide mass vaccination setting","volume":"139","author":"Mittelman","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.lanmic.2026.101424_bib52","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s11684-023-0995-9","article-title":"Protection of inactivated vaccine against SARS-CoV-2 infections in patients with comorbidities: a prospective cohort study","volume":"17","author":"Ngaosuwan","year":"2023","journal-title":"Front Med"},{"key":"10.1016\/j.lanmic.2026.101424_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104761","article-title":"mRNA versus inactivated virus COVID-19 vaccines in multiple sclerosis: humoral responses and protectivity\u2014Does it matter?","volume":"75","author":"T\u00fct\u00fcnc\u00fc","year":"2023","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.lanmic.2026.101424_bib54","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1001\/jamaoncol.2022.1096","article-title":"Breakthrough SARS-CoV-2 infections, hospitalizations, and mortality in vaccinated patients with cancer in the US between December 2020 and November 2021","volume":"8","author":"Wang","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.lanmic.2026.101424_bib55","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/apt.17661","article-title":"STAR SIGN study: evaluation of COVID-19 vaccine efficacy against the SARS-CoV-2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease","volume":"58","author":"Woelfel","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.lanmic.2026.101424_bib56","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.165111","article-title":"T cell responses to SARS-CoV-2 vaccination differ by disease-modifying therapy for multiple sclerosis","volume":"8","author":"Wolf","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.lanmic.2026.101424_bib57","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s42358-023-00335-x","article-title":"COVID-19 vaccination of patients with chronic immune-mediated inflammatory disease","volume":"63","author":"Yanfang","year":"2023","journal-title":"Adv Rheumatol"},{"key":"10.1016\/j.lanmic.2026.101424_bib58","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.healthpol.2022.05.005","article-title":"Prioritization of COVID-19 vaccination. The added value of the \u201cVALIDATE\u201d approach","volume":"126","author":"Refolo","year":"2022","journal-title":"Health Policy"},{"key":"10.1016\/j.lanmic.2026.101424_bib62","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.tmaid.2018.05.016","article-title":"Incidence of invasive pneumococcal disease in immunocompromised patients: a systematic review and meta-analysis","volume":"24","author":"van Aalst","year":"2018","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101424_bib63","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12879-018-3002-3","article-title":"Burden of severe RSV disease among immunocompromised children and adults: a 10 year retrospective study","volume":"18","author":"Chatzis","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101424_bib65","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1016\/j.vaccine.2023.04.075","article-title":"Vaccine effectiveness of the mRNA-1273 3-dose primary series against COVID-19 in an immunocompromised population: a prospective observational cohort study","volume":"41","author":"Ku","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.lanmic.2026.101424_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.126966","article-title":"Durability of COVID-19 vaccine and infection induced immunity: A systematic review and meta-regression analysis","volume":"54","author":"Moore","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.lanmic.2026.101424_bib67","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1136\/ard-2022-222550","article-title":"Immunogenicity induced by two and three doses of the BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic diseases and immunocompetent controls: a longitudinal multicentre study","volume":"81","author":"Furer","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lanmic.2026.101424_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102981","article-title":"Accelerated waning of immune responses to a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases","volume":"135","author":"Mrak","year":"2023","journal-title":"J Autoimmun"},{"key":"10.1016\/j.lanmic.2026.101424_bib69","doi-asserted-by":"crossref","first-page":"271","DOI":"10.15585\/mmwr.mm7312a5","article-title":"Interim effectiveness of updated 2023\u20132024 (monovalent XBB.1.5) COVID-19 vaccines against COVID-19\u2013associated hospitalization among adults aged \u226518 years with immunocompromising conditions\u2014VISION network, September 2023\u2013February 2024","volume":"73","author":"Link-Gelles","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.lanmic.2026.101424_bib70","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/apt.18349","article-title":"XBB. 1.5-adapted COVID-19 mRNA vaccines but not infections with previous omicron variants boost neutralisation against the SARS\u2013CoV-2 JN.1 variant in patients with inflammatory bowel disease","volume":"61","author":"Woelfel","year":"2025","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.lanmic.2026.101424_bib71","series-title":"COVID-19 vaccine effectiveness in people on immunosuppressive therapies: SR and meta-analysis (Version v1.0) [Computer software]","author":"Stadler","year":"2026"}],"container-title":["The Lancet Microbe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666524726000790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666524726000790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T11:36:53Z","timestamp":1790595413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666524726000790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":67,"alternative-id":["S2666524726000790"],"URL":"https:\/\/doi.org\/10.1016\/j.lanmic.2026.101424","relation":{},"ISSN":["2666-5247"],"issn-type":[{"value":"2666-5247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 vaccine effectiveness in people on immunosuppressive therapies: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"The Lancet Microbe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanmic.2026.101424","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101424"}}